Details of the Drug Reposition

General Information of This Drug (ID: DMZ2G69)

Drug Name
Navicixizumab   DMZ2G69

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Colorectal cancer DISNH7P9 2B91.Z Phase 1 [1]
Peritoneal cavity cancer DISBT2JS 2C51.Z Phase 1 [2]
Ovarian cancer DISZJHAP 2C73 Phase 1 [1]
Fallopian tube cancer DISXHWCS 2C74 Phase 1 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)